| 789858 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells |
2022-01-01 |
10.1136/jitc-2021-002500 |
Bajor Malgorzata, Graczyk-Jarzynka Agnieszka, Marhelava Katsiaryna, Burdzinska Anna, Muchowicz Angelika, Goral Agnieszka, Zhylko Andriy, Soroczynska Karolina, Retecki Kuba, Krawczyk Marta, Klopotowska Marta, Pilch Zofia, Paczek Leszek, Malmberg Karl-Johan, Wälchli Sébastien, Winiarska Magdalena, Zagozdzon Radoslaw |
| 789857 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapies |
2022-01-01 |
10.1136/jitc-2021-003024 |
Michielin Olivier, Lalani Aly-Khan, Robert Caroline, Sharma Padmanee, Peters Solange |
| 789856 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders |
2022-01-01 |
10.1136/jitc-2021-004034 |
Zhou Liye, Zeng Zexian, Egloff Ann Marie, Zhang Fan, Guo Fei, Campbell Katie M, Du Peter, Fu Jingxin, Zolkind Paul, Ma Xiaojing, Zhang Zhe, Zhang Yi, Wang Xiaoqing, Gu Shengqing, Riley Rachel, Nakahori Yasutaka, Keegan Joshua, Haddad Robert, Schoenfeld Jonathan D, Griffith Obi, Manguso Robert T, Lederer James A, Liu X Shirley, Uppaluri Ravindra |
| 789855 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study |
2022-01-01 |
10.1136/jitc-2021-003697 |
Zucali Paolo Andrea, Lin Chia-Chi, Carthon Bradley C, Bauer Todd M, Tucci Marcello, Italiano Antoine, Iacovelli Roberto, Su Wu-Chou, Massard Christophe, Saleh Mansoor, Daniele Gennaro, Greystoke Alastair, Gutierrez Martin, Pant Shubham, Shen Ying-Chun, Perrino Matteo, Meng Robin, Abbadessa Giovanni, Lee Helen, Dong Yingwen, Chiron Marielle, Wang Rui, Loumagne Laure, Lépine Lucie, de Bono Johann |
| 789854 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors |
2022-01-01 |
10.1136/jitc-2021-003488 |
Semmrich Monika, Marchand Jean-Baptiste, Fend Laetitia, Rehn Matilda, Remy Christelle, Holmkvist Petra, Silvestre Nathalie, Svensson Carolin, Kleinpeter Patricia, Deforges Jules, Junghus Fred, Cleary Kirstie L, Bodén Mimoza, Mårtensson Linda, Foloppe Johann, Teige Ingrid, Quéméneur Eric, Frendéus Björn |
| 789853 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy |
2022-01-01 |
10.1136/jitc-2021-003779 |
Jing Ying, Chen Xue, Li Kunyan, Liu Yaoming, Zhang Zhao, Chen Yiqing, Liu Yuan, Wang Yushu, Lin Steven H, Diao Lixia, Wang Jing, Lou Yanyan, Johnson Douglas B, Chen Xiang, Liu Hong, Han Leng |
| 789852 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Fine-tuned long-acting interleukin-2 superkine potentiates durable immune responses in mice and non-human primate |
2022-01-01 |
10.1136/jitc-2021-003155 |
Merchant Rosemina, Galligan Carole, Munegowda Manjunatha Ankathatti, Pearce L Bruce, Lloyd Peter, Smith Paul, Merchant Fahar, To Minh D |
| 789851 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
JAK and mTOR inhibitors prevent cytokine release while retaining T cell bispecific antibody in vivo efficacy |
2022-01-01 |
10.1136/jitc-2021-003766 |
Leclercq Gabrielle, Haegel Hélène, Toso Alberto, Zimmermann Tina, Green Luke, Steinhoff Nathalie, Sam Johannes, Pulko Vesna, Schneider Anneliese, Giusti Anna Maria, Challier John, Freimoser-Grundschober Anne, Larivière Laurent, Odermatt Alex, Stern Martin, Umana Pablo, Bacac Marina, Klein Christian |
| 789850 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, singl |
2022-01-01 |
10.1136/jitc-2021-003777 |
Oaknin Ana, Gilbert Lucy, Tinker Anna V, Brown Jubilee, Mathews Cara, Press Joshua, Sabatier Renaud, O’Malley David M, Samouelian Vanessa, Boni Valentina, Duska Linda, Ghamande Sharad, Ghatage Prafull, Kristeleit Rebecca, Leath III Charles, Guo Wei, Im Ellie, Zildjian Sybil, Han Xinwei, Duan Tao, Veneris Jennifer, Pothuri Bhavana |
| 789849 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor |
2022-01-01 |
10.1136/jitc-2021-003131 |
Zilio Serena, Bicciato Silvio, Weed Donald, Serafini Paolo |
